Literature DB >> 6469088

Peritoneal cytology in patients with squamous cell carcinoma of the cervix.

L C Kilgore, J W Orr, K D Hatch, H M Shingleton, J Roberson.   

Abstract

The importance of peritoneal cytology was investigated in 163 patients with squamous cell carcinoma of the cervix. Of 116 patients undergoing primary evaluation and treatment 3 (2.5%) had abnormal cytology. No abnormal specimens were found in 77 patients undergoing radical hysterectomy. Five (10.6%) of forty-seven patients evaluated and treated for posttreatment recurrence had abnormal cytology. All eight patients with abnormal cytology had other poor prognostic factors and are dead of cancer. The relevance of abnormal cytology is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6469088     DOI: 10.1016/0090-8258(84)90153-7

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer.

Authors:  Shiho Kuji; Yasuyuki Hirashima; Satomi Komeda; Aki Tanaka; Masakazu Abe; Nobutaka Takahashi; Munetaka Takekuma
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

2.  Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study.

Authors:  Koji Matsuo; Muneaki Shimada; Shinya Matsuzaki; Hiroko Machida; Yoshikazu Nagase; Toshiaki Saito; Shoji Kamiura; Takashi Iwata; Toru Sugiyama; Mikio Mikami
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

Review 3.  Diagnostic Cytopathology of Peritoneal Washings.

Authors:  Rosemary E Zuna
Journal:  Cytojournal       Date:  2022-02-28       Impact factor: 2.345

4.  The impact of positive peritoneal cytology on prognosis in patients with cervical cancer: a meta-analysis.

Authors:  Sang-Hee Yoon; Soo-Nyung Kim; Seung-Hyuk Shim; Ji-Young Lee; Sun-Joo Lee; In-Kyeong Oh; Hyeon-Jeong Kim; Soon-Beom Kang
Journal:  Br J Cancer       Date:  2015-07-30       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.